About 10 results found for searched term "CP05" (0.051 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1820 | Tofacitinib | JAK |
| CP-690550, Tasocitinib | ||
| Tofacitinib (formerly tasocitinib, CP-690550) is a novel Janus Kinase 3 (JAK-3) kinase inhibitor with an IC50 value estimated at 0.2 μM. | ||
| M3616 | Tofacitinib citrate | JAK |
| CP-690550 citrate | ||
| Tofacitinib (CP-690550) Citrate is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1. | ||
| M6064 | Ziprasidone HCl | 5-HT Receptor |
| CP-88059 | ||
| Ziprasidone HCl is a novel and potent dopamine and serotonin (5-HT) receptor antagonist, used in the treatment of schizophrenia and bipolar disorder. | ||
| M6065 | Ziprasidone HCl monohydrate | 5-HT Receptor |
| CP 88059 | ||
| Ziprasidone(CP88059) is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects of antipsychotic activity. | ||
| M8116 | CP-105,696 | Leukotriene Receptor |
| CP-105,696 is an orally active, potent and selective leukotriene B4 receptor (LTB4R) antagonist (IC50 against [3H]LTB4 = 5. | ||
| M9679 | CP671305 | PDE |
| CP-671,305 | ||
| CP671305 is a potent and selective, orally active inhibitor of phosphodiesterase-4-D with high activities. | ||
| M9936 | CPI-1205 | EZH2 |
| Lirametostat; CPI1205 | ||
| CPI-1205 is a highly potent (biochemical IC50 = 0.002 μM, cellular EC50 = 0.032 μM) and selective inhibitor of EZH2. | ||
| M13881 | Ziprasidone | 5-HT Receptor |
| CP-88059 | ||
| Ziprasidone, an antipsychotic agent, is a combined 5-HT (serotonin) and dopamine receptor antagonist. | ||
| M14614 | ACP-105 | Androgen Receptor |
| ACP-105 is an orally available, selective amd potent androgen receptor modulator (SARM), with pEC50s of 9.0 and 9.3 for AR wild type and T877A mutant, respectively. | ||
| M58139 | CP05 | Others |
| CRHSQMTVTSRL | ||
| CP05 (CRHSQMTVTSRL) is a peptide with high affinity to exosomal CD63. The specific exosomal anchor peptide CP05 acted as a flexible linker and effectively combined the engineered exosome nanoparticles with 3D-printed porous bone scaffolds. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
